Galderma’s Nemluvio gains FDA nod for moderate-to-severe atopic dermatitis
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of Nemluvio (nemolizumab) for treating moderate-to-severe atopic dermatitis in patients ... Read More
Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success
Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition characterized by relentless itching and thickened skin ... Read More
Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for the treatment of prurigo nodularis in adults. ... Read More
Galderma and L’Oréal join forces to advance dermatology
Galderma, renowned for its leadership in dermatology, and L’Oréal, a giant in beauty and skincare, have unveiled a groundbreaking partnership marked by L’Oréal acquiring a ... Read More
Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The ... Read More
Zydus Cadila gets FDA tentative approval for acne treatment generic
Zydus Cadila has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. A generic of ... Read More
Alembic Pharmaceuticals gets FDA approval for Metronidazole Gel USP, 1 %
Alembic Pharmaceuticals said that its joint venture - Aleor Dermaceuticals has secured tentative approval from the US Food and Drug Administration (FDA) for its abbreviated ... Read More
Galderma launches phase 3 atopic dermatitis trial for nemolizumab
Galderma, a Nestle-owned Swiss pharma company, said that it has enrolled the first patients in a phase 3 clinical study evaluating nemolizumab for the treatment ... Read More